ALL-REMOTE COMPANY/WILMINGTON, Del. / Sep 30, 2025 / Business Wire / Phreesia, a leader in patient intake, outreach and activation, has been named to TIME’s list of the World’s Top HealthTech Companies of 2025. The list, developed in partnership with Statista, highlights health tech companies that drive innovation, enhance accessibility, and contribute to a more effective and sustainable healthcare ecosystem.
“Digital health’s primary benefit will be in empowering patients to both learn more about their health, and also to take action to either avoid or manage conditions better,” TIME said in its announcement of the inaugural list.
Organizations were ranked based on financial performance, reputation analysis and online engagement, and categorized into six different market segments. Phreesia received a ‘very high’ performance indicator in the Health Information & Management category.
“We are honored to be named one of TIME’s top health tech companies,” said Phreesia CEO Chaim Indig. “Phreesia’s vision is for every person to take an active role in their care, and we believe our digital solutions help patients and providers do just that. Facilitating 170 million patient visits annually gives us the scale to make a meaningful impact.”
For more information on Phreesia, visit www.phreesia.com.
About Phreesia
Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024—1 in 7 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit www.phreesia.com.
| Last Trade: | US$23.69 |
| Daily Change: | 0.28 1.20 |
| Daily Volume: | 124,625 |
| Market Cap: | US$1.420B |
September 04, 2025 September 04, 2025 September 02, 2025 May 28, 2025 March 12, 2025 | |

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load